Contestant: Susan Mangiero, Managing member, Business Valuation Analytics Member, National Association of Certified Valuation Analysts Not being too familiar with derivative instrument pricing and default risk analysis, a company hires an expert to investigate whether the swaps reflect a hedge versus a market bet and to further assess how the company should adjust the valuation of its equity stake. What does the expert need to look at and how should she arrive at an appropriate conclusion?
3 min read · 08 February 2013
In the second in a two-part series on debt buybacks, Steven Bortnick, Bradley Boericke and Timothy Leska explore the tax implications of structuring a debt purchase. In our January issue, they examined the legal implications.
8 min read · 08 February 2013
News on professional service providers to the private equity market.
7 min read · 08 February 2013
The total value of private equity activity in Italy soared in the first half of 2008, but by the end of the year deal-doing was largely off the agenda. Reporting from Milan, Andy Thomson asks what happens next
5 min read · 08 February 2013
Three recent surveys reveal that investors in private equity funds are hindered by practicalities and frustrated by GP attitudes but excited by long-term performance. Andy Thomson reprts
3 min read · 08 February 2013
What lies in store for the 2009 fundraising market? PEI assesses the mood of limited partners around the world and finds out which LPs have risen to the top of the popularity stakes. By Matt Levin
10 min read · 08 February 2013
Listed French private equity firm Eurazeo is keeping a close eye on its portfolio companies while resisting the temptation to micro-manage. Andy Thomson met with executive board chairman Patrick Sayer, who is confident he can ride the economic storm – and maybe even give a boost to his firm's ailing share price
7 min read · 08 February 2013
In the absence of exit opportunities, venture firms are increasingly turning to the secondaries market to generate liquidity. Christopher Witkowsky reports
3 min read · 08 February 2013
A UK diagnostics firm is launching an aggressive growth strategy
1 min read · 08 February 2013
Christopher Flowers should be making hay. But at the outset of an historic buying opportunity, why are some of his firm's limited partners running for cover? Matt Levin and David Snow investigate
6 min read · 08 February 2013
